PubMed Health⌕ Search

PubMed · 17167883

Misconceptions concerning influenza: an overview and clear answers.

Abstract

An interactive session exposed the common misconceptions about vaccination. The session chair persons, Dr. A. Monto of the University of Michigan and Dr. A.D.M.E. Osterhaus of the Erasmus Medical Centre in The Netherlands, showed video clips of healthcare workers making controversial statements about vaccination. After reacting to the video clips, Monto and Osterhaus entered into a lively debate with members of the audience. Misconceptions and misinformation concerning influenza are widespread, even amongst the medical community. Many people believe that influenza is a relatively benign disease, and that contracting it is an unavoidable fact of life. These people do not realise that getting vaccinated can provide them with a substantial degree of protection. Many also fear "side effects" even though the influenza vaccine rarely induces severe influenza-like illness (ILI) much less any other side effects. Some people feel that it is simply not worth getting vaccinated since they only catch the flu once every 10 years. The probability of being infected by the virus can be quite high for some groups, however,and the consequences of infection - debilitating illness, loss of mobility, secondary infections - can be particularly severe for high-risk groups. Vaccination is still limited to only 17% of the population in the EU countries but ESWI hopes to change that. A direct result of the conference was the decision to promote vaccination of one-third of the population - or about 150 million people - in the 25 EU countries by 2010.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

2006-11-10. Misconceptions concerning influenza: an overview and clear answers.. https://doi.org/10.1016/j.vaccine.2006.06.071

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Quality of life in age-related macular degeneration: a review of the literature.

BACKGROUND: The Age-related Macular Degeneration Alliance International commissioned a review of the literature on quality of life (QoL) in macular degeneration (MD) with a view to increasing awareness of MD, reducing its impact and improving services for people with MD worldwide. METHOD: A systematic review was conducted using electronic databases, conference proceedings and key journal hand search checks. The resulting 'White Paper' was posted on the AMD Alliance website and is reproduced here. REVIEW: MD is a chronic, largely untreatable eye condition which leads to loss of central vision needed for tasks such as reading, watching TV, driving, recognising faces. It is the most common cause of blindness in the Western world. Shock of diagnosis, coupled with lack of information and support are a common experience. Incidence of depression is twice that found in the community-dwelling elderly, fuelled by functional decline and loss of leisure activities. Some people feel suicidal. MD threatens independence, especially when comorbidity exacerbates functional limitations. Rehabilitation, including low vision aid (LVA) provision and training, peer support and education, can improve functional and psychological outcomes but many people do not receive services likely to benefit them. Medical treatments, suitable for only a small minority of people with MD, can improve vision but most limit progress of MD, at least for a time, rather than cure. The White Paper considers difficulties associated with inappropriate use of health status measures and misinterpretation of utility values as QoL measures: evidence suggests they have poor validity in MD. CONCLUSION: There is considerable evidence for the major damage done to QoL by MD which is underestimated by health status and utility measures. Medical treatments are limited to a small proportion of people. However, much can be done to improve QoL by early diagnosis of MD with good communication of prognosis and continuing support. Support could include provision of LVAs, peer support, education and effective help in adjusting to MD. It is vital that appropriate measures of visual function and QoL be used in building a sound evidence base for the effectiveness of rehabilitation and treatment.

Health Knowledge, Attitudes, Practice↗